MedPath

Investigating the effect of prescribing olanzapine on reducing the amount of midazolam and fentanyl and preventing delirium

Phase 3
Recruiting
Conditions
delirium.
Delirium due to known physiological condition
Registration Number
IRCT20240319061337N1
Lead Sponsor
Ilam University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
72
Inclusion Criteria

Mechanically ventilated patients hospitalized in the intensive care unit.

Exclusion Criteria

Patients who have a history of using narcotic drugs.
Patients who have a history of taking antipsychotic drugs.
Patients who have a history of neurological and psychiatric diseases and neurological/neurosurgical diseases.

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath